Smoking cessation: the psychiatrist's role.
Delva
Nicholas J
NJ
Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia.
D018692:Antimanic Agents / Q000627:therapeutic use; D001552:Benzazepines / Q000494:pharmacology / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology*; D016642:Bupropion / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D016651:Lithium Carbonate / Q000627:therapeutic use; D011570:Psychiatry / Q000379:methods*; D011810:Quinoxalines / Q000494:pharmacology / Q000627:therapeutic use; D011978:Receptors, Nicotinic / Q000187:drug effects; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention; D000068580:Varenicline
D018692:Antimanic Agents; D001552:Benzazepines; D011810:Quinoxalines; D011978:Receptors, Nicotinic; D016642:Bupropion; D016651:Lithium Carbonate; D000068580:Varenicline
CMAJ. 2007 Nov 20;177(11):1373-80
18025429
Am J Psychiatry. 2003 Dec;160(12):2228-30
14638595
Am J Psychiatry. 2007 Aug;164(8):1269
17671295
Br J Addict. 1991 Sep;86(9):1119-27
1932883
Am J Psychiatry. 2007 Aug;164(8):1269-70
17671294
Ann Pharmacother. 2008 Feb;42(2):288-9
18198241